BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1465862)

  • 1. Phenotypic and functional analysis of graft-infiltrating cells following therapy with anti-interleukin-2 receptor monoclonal antibody and cyclosporine A in the rat.
    Sido B; Morris PJ; Dallman M
    Transplant Proc; 1992 Dec; 24(6):2549-50. PubMed ID: 1465862
    [No Abstract]   [Full Text] [Related]  

  • 2. Local immunosuppressive therapy with monoclonal anti-T-cell antibody on renal allograft survival in the rat. II. Phenotypic and functional assessment of spleen cells.
    Yoshimura N; Lee CJ; Shiho O; Kita M; Imanishi J; Oka T
    Transplant Proc; 1995 Feb; 27(1):390-1. PubMed ID: 7879033
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of anti-IL-2-receptor monoclonal antibody BT 563 in treatment of acute interstitial renal rejection.
    Carl S; Wiesel M; Daniel V; Staehler G
    Transplant Proc; 1995 Feb; 27(1):854-5. PubMed ID: 7879205
    [No Abstract]   [Full Text] [Related]  

  • 4. Flow cytometric measurements in 104 anti-T-lymphocyte globulin treatments.
    Ekberg H; Persson NH; Olsson M; Lundell A; Bredberg A
    Transplant Proc; 1992 Dec; 24(6):2551-2. PubMed ID: 1465863
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
    van Gelder T; Knoop CJ; Hesse CJ; Vaessen LM; Balk AH; Yzermans JN; Weimar W
    Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of anti-IL 2 receptor monoclonal antibody and cyclosporine on IL 2 receptor-positive cells infiltrating cardiac allografts in the rat.
    Lord RH; Hancock WW; Colby AJ; Padberg W; Diamantstein T; Kupiec-Weglinski JW; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):354-5. PubMed ID: 3079156
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
    Harrison PC; Mainolfi E; Madwed JB
    J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and functional analysis of kidney infiltrating T cells escaping monoclonal antibody treatment in primate renal transplantation.
    Nocera A; Cosimi AB; Colvin RB; Gesner ML; Fuller TC
    Transplant Proc; 1988 Apr; 20(2):205-6. PubMed ID: 3129830
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of cyclosporin A dose on the function of the transplanted kidney. Peripheral mononuclear cells and histological findings in the transplant].
    Leimenstoll G
    Fortschr Med; 1991 Nov; 109(32):659-60. PubMed ID: 1769633
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study.
    Kriaa F; Hiesse C; Alard P; Lantz O; Noury J; Charpentier B; Bazin H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):817-9. PubMed ID: 8438496
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitory effect of the complement receptor-specific monoclonal antibody on the induced antibody response and the role of CD4+ and CD8+ T-cells in the rat to mouse xenotransplantation.
    Matsumiya G; Shirakura R; Miyagawa S; Nakata S; Nakano S; Kinoshita T; Matsuda H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):402-4. PubMed ID: 8438354
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence and impact of acute rejection episodes on short- and long-term graft survival in recipients of simultaneous pancreas-kidney transplantation.
    Cantarovich D; Giral M; Josien R; Karam G; Hourmant M; Dantal J; Blancho G; Soulillou JP
    Transplant Proc; 1995 Feb; 27(1):1319. PubMed ID: 7878897
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K
    Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction of cyclosporine A with interleukin 2 receptor monoclonal antibody therapy.
    Tellides G; Dallman MJ; Morris PJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):202-6. PubMed ID: 3129840
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up after induction treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in kidney allograft recipients: a double-blind, placebo-controlled trial.
    van Gelder T; Zietse R; Yzermans JN; Rischen-Vos J; Vaessen LM; Weimar W
    Transplant Proc; 1996 Dec; 28(6):3221-2. PubMed ID: 8962247
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of a primate model of renal transplantation in the development of new monoclonal antibodies.
    Shapiro ME; Reed MH; Strom TB; Carpenter CB; Milford EL; Kirkman RL
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):58-60. PubMed ID: 2816938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of natural killer cells in mediating graft-versus-host disease following small bowel transplantation in a rat model.
    Fändrich F; Exner B; Papachrysanthou A; Jahnke T; Chambers WH; Zavazava N
    Transplant Proc; 1996 Oct; 28(5):2465-6. PubMed ID: 8907904
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug exposure and flow cytometry analyses in a thalidomide treatment schedule that prolongs rat cardiac graft survival.
    Eriksson T; Riesbeck K; Ostraat O; Ekberg H; Björkman S
    Transplant Proc; 1992 Dec; 24(6):2560-1. PubMed ID: 1465866
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of activated natural killer and CD4+, CD8+ cells in the cellular rejection of a discordant xenograft.
    Elsen M; Soares M; Latinne D; Cornet A; Bazin H
    Transplant Proc; 1993 Feb; 25(1 Pt 1):447-9. PubMed ID: 8438373
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival, function, morphology and serological aspects of rat renal allografts. Effect of short-term treatment with cyclosporine A, anti-CD4 and anti-interleukin-2 receptor monoclonal antibodies.
    Steinbrüchel DA; Larsen S; Kristensen T; Starklint H; Koch C; Kemp E
    APMIS; 1992 Aug; 100(8):682-94. PubMed ID: 1520480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.